Qiagen N.V. (ETR:QIA)

Market Cap	8.75B -5.1%
Revenue (ttm)	1.78B +5.7%
Net Income	361.87M +408.3%
EPS	1.74 +409.8%
Shares Out	n/a
PE Ratio	24.19
Forward PE	19.43
Dividend	2.18 (5.06%)
Ex-Dividend Date	Jan 8, 2026

Volume	505,307
Average Volume	820,568
Open	42.77
Previous Close	42.85
Day's Range	42.70 - 43.99
52-Week Range	36.04 - 47.60
Beta	0.68
RSI	50.61
Earnings Date	Feb 4, 2026

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1984
• Employees: 5,654
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: QIA

Financial Performance

In 2025, Qiagen's revenue was $2.09 billion, an increase of 5.65% compared to the previous year's $1.98 billion. Earnings were $424.88 million, an increase of 408.28%.

Financial numbers in USD